Vertex Pharmaceuticals: Clinical Trials & Research Profile
Biopharma Industry (Boston, MA) · Primary Focus: Respiratory and Pulmonary
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Boston, MA) |
| Primary Therapeutic Area | Respiratory and Pulmonary |
| Active Phase II & III Studies | 26 active (11 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 78 (51 with California sites) |
| Completed vs Early-Stopped Studies | 48 completed / 4 stopped (5.1% stop rate) |
| Median Closed Enrollment | 87 participants |
| FDA Drugs@FDA Original Approvals | 10 all-time (6 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 96.9% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Vertex Pharmaceuticals across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk